TrialDer Urologe. Ausg. A2014
[Is the validated ICIQ-SF suitable for evaluation of OAB patients? A data analysis of intravesicular botulinum toxin therapy].
J Paas et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it